GLP1R and diabetes mellitus: Long-term treatment with two classes of drugs for DM—glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose cotransporter-2 inhibitors (SGLT-2i)—demonstrated cardiovascular and renal protection in addition to their glucose-lowering effect [9–13].